Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Curry

Showing results (221-230 of 247) with videos related to

Pageof 25
Sort By:
Cell|April 15, 2014
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cellsMario L Suvà, Esther Rheinbay, Shawn M Gillespie, et al.
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.
Neuro-Oncology|December 15, 2025
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular ImmunotherapyEric P Grewal, Samuel J Steuart, Baolin Liu, et al.
Nature Medicine|August 15, 2018
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma PatientsK Ina Ly, Leland G Richardson, Mofei Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Bone cancerJ Sybil Biermann, Douglas R Adkins, Mark Agulnik, et al.
Nature Communications|March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomasPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
The New England Journal of Medicine|July 12, 2023
BRAF-MEK Inhibition in Newly Diagnosed Papillary CraniopharyngiomasPriscilla K Brastianos, Erin Twohy, Susan Geyer, et al.
Cancer Cell|December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ DepletionKensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Pageof 25

Showing results (221-230 of 247) with videos related to

Sort By:
Pageof 25
Cell|April 15, 2014
Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cellsMario L Suvà, Esther Rheinbay, Shawn M Gillespie, et al.
Neuro-Oncology|April 6, 2024
Radical surgical resection with molecular margins is associated with improved survival in IDH wild-type glioblastomaElie Massaad, William J Smith, Joseph Bradley, et al.
Neuro-Oncology|December 15, 2025
Tumor-Infiltrating Lymphocyte Therapy Generated from Melanoma Brain Metastasis: Proof-of-Concept for CNS-Derived Cellular ImmunotherapyEric P Grewal, Samuel J Steuart, Baolin Liu, et al.
Nature Medicine|August 15, 2018
Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Nature Medicine|January 24, 2019
Author Correction: Sequestration of T cells in bone marrow in the setting of glioblastoma and other intracranial tumorsPakawat Chongsathidkiet, Christina Jackson, Shohei Koyama, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2023
Bavituximab Decreases Immunosuppressive Myeloid-Derived Suppressor Cells in Newly Diagnosed Glioblastoma PatientsK Ina Ly, Leland G Richardson, Mofei Liu, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 8, 2013
Bone cancerJ Sybil Biermann, Douglas R Adkins, Mark Agulnik, et al.
Nature Communications|March 15, 2022
Phase 2 study of pembrolizumab in patients with recurrent and residual high-grade meningiomasPriscilla K Brastianos, Albert E Kim, Anita Giobbie-Hurder, et al.
The New England Journal of Medicine|July 12, 2023
BRAF-MEK Inhibition in Newly Diagnosed Papillary CraniopharyngiomasPriscilla K Brastianos, Erin Twohy, Susan Geyer, et al.
Cancer Cell|December 19, 2015
Extreme Vulnerability of IDH1 Mutant Cancers to NAD+ DepletionKensuke Tateishi, Hiroaki Wakimoto, A John Iafrate, et al.
Pageof 25